Narimon Honarpour
AuthID: R-00H-PQP
1
TITLE: Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction A Prespecified Secondary Analysis From the FOURIER Trial
AUTHORS: Baris Gencer; Francois Mach; Sabina A Murphy; Gaetano M De Ferrari; Kurt Huber; Basil S Lewis; Jorge Ferreira; Christopher E Kurtz; Huei E Wang; Narimon Honarpour; Anthony C Keech; Peter S Sever; Terje R Pedersen; Marc S Sabatine; Robert P Giugliano;
PUBLISHED: 2020, SOURCE: JAMA CARDIOLOGY, VOLUME: 5, ISSUE: 8
AUTHORS: Baris Gencer; Francois Mach; Sabina A Murphy; Gaetano M De Ferrari; Kurt Huber; Basil S Lewis; Jorge Ferreira; Christopher E Kurtz; Huei E Wang; Narimon Honarpour; Anthony C Keech; Peter S Sever; Terje R Pedersen; Marc S Sabatine; Robert P Giugliano;
PUBLISHED: 2020, SOURCE: JAMA CARDIOLOGY, VOLUME: 5, ISSUE: 8
INDEXED IN: 
Scopus 
WOS
Scopus WOS2
TITLE: Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER
AUTHORS: Marc S Sabatine; Gaetano M De Ferrari; Robert P Giugliano; Kurt Huber; Basil S Lewis; Jorge Ferreira; Julia F Kuder; Sabina A Murphy; Stephen D Wiviott; Christopher E Kurtz; Narimon Honarpour; Anthony C Keech; Peter S Sever; Terje R Pedersen;
PUBLISHED: 2018, SOURCE: CIRCULATION, VOLUME: 138, ISSUE: 8
AUTHORS: Marc S Sabatine; Gaetano M De Ferrari; Robert P Giugliano; Kurt Huber; Basil S Lewis; Jorge Ferreira; Julia F Kuder; Sabina A Murphy; Stephen D Wiviott; Christopher E Kurtz; Narimon Honarpour; Anthony C Keech; Peter S Sever; Terje R Pedersen;
PUBLISHED: 2018, SOURCE: CIRCULATION, VOLUME: 138, ISSUE: 8
INDEXED IN: WOS
WOS